Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
RGSS.ME Stock Summary
In the News
RGSS.ME Financial details
Company Rating
Strong Buy
Market Cap
61.48B
Income
12.58B
Revenue
214.65B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
12.45K
Optionable
No
Shortable
Yes
Earnings
28 Feb 2024
P/E
12.49
Forward P/E
-
PEG
0.3
P/S
0.66
P/B
1.14
P/C
-
P/FCF
-42.88
Quick Ratio
0.1
Current Ratio
0.1
Debt / Equity
0.03
LT Debt / Equity
0.03
-
-
EPS (TTM)
0.03
EPS next Y
-
EPS next Q
-
EPS this Y
102%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-4.17%
Revenue last 5Y
4.07%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
4%
ROE
9%
ROC
0.07%
Gross Margin
100%
Oper. Margin
10%
Profit Margin
5%
Payout
-
Shs Outstand
489.5B
Shs Float
0
-
-
-
-
Target Price
-
52W Range
0.1238-0.1312
52W High
-
52W Low
-
RSI
23
Rel Volume
-
Avg Volume
-
Volume
1.55M
Perf Week
-38.19%
Perf Month
-29.83%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
0.602
-
-
Volatility
0.02%, 0.01%
Prev Close
-29.6%
Price
0.1256
Change
-29.83%
RGSS.ME Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.16 | 0.2 | 0.22 | 0.23 | 0.19 | |
Net income per share | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | |
Operating cash flow per share | 0.01 | 0.02 | 0.04 | 0.06 | 0 | |
Free cash flow per share | 0.01 | 0.02 | 0.04 | 0.06 | 0 | |
Cash per share | 0.01 | 0.01 | 0.03 | 0.04 | 0 | |
Book value per share | 0.09 | 0.11 | 0.1 | 0.1 | 0.11 | |
Tangible book value per share | 0.09 | 0.1 | 0.09 | 0.09 | 0.1 | |
Share holders equity per share | 0.09 | 0.11 | 0.1 | 0.1 | 0.11 | |
Interest debt per share | 0.02 | 0.01 | 0 | 0.01 | 0 | |
Market cap | 80.08B | 68.46B | 150.02B | 89.09B | 64.22B | |
Enterprise value | 79.3B | 69.9B | 150.84B | 89.85B | 65.62B | |
P/E ratio | 13.12 | 8.92 | 19.69 | 36.36 | 13.05 | |
Price to sales ratio | 1.05 | 0.71 | 1.41 | 0.8 | 0.69 | |
POCF ratio | 11.38 | 6.76 | 7.27 | 3.02 | 117.71 | |
PFCF ratio | 13.12 | 8.07 | 7.99 | 3.22 | -44.79 | |
P/B Ratio | 1.78 | 1.3 | 3.12 | 1.77 | 1.19 | |
PTB ratio | 1.78 | 1.3 | 3.12 | 1.77 | 1.19 | |
EV to sales | 1.04 | 0.73 | 1.41 | 0.81 | 0.71 | |
Enterprise value over EBITDA | 11.72 | 7.87 | 16.03 | 30.53 | 6.07 | |
EV to operating cash flow | 11.26 | 6.9 | 7.31 | 3.05 | 120.26 | |
EV to free cash flow | 12.99 | 8.24 | 8.03 | 3.25 | -45.77 | |
Earnings yield | 0.08 | 0.11 | 0.05 | 0.03 | 0.08 | |
Free cash flow yield | 0.08 | 0.12 | 0.13 | 0.31 | -0.02 | |
Debt to equity | 0.2 | 0.05 | 0.04 | 0.06 | 0.03 | |
Debt to assets | 0.06 | 0.02 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | -0.11 | 0.16 | 0.09 | 0.26 | 0.13 | |
Current ratio | 1.42 | 1.26 | 2.12 | 2.41 | 0.1 | |
Interest coverage | 0 | 89.71 | 42.44 | 19.47 | 55.66 | |
Income quality | 1.15 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0.14 | 0 | |
Payout ratio | 0 | 0 | 0 | 5 | 0 | |
Sales general and administrative to revenue | 0.07 | 0.05 | 0.04 | 0.09 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.02 | 0.02 | 0.04 | |
Capex to operating cash flow | -0.13 | -0.16 | -0.09 | -0.06 | -3.63 | |
Capex to revenue | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | |
Capex to depreciation | -1 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.16 | 0.2 | 0.19 | 0.11 | 0.16 | |
ROIC | 0.11 | 0.15 | 0.13 | 0.03 | 0.13 | |
Return on tangible assets | 0.04 | 0.05 | 0.04 | 0.01 | 0.04 | |
Graham Net | -0.18 | -0.21 | -0.25 | -0.28 | -0.17 | |
Working capital | 2.02B | 1.35B | 8.38B | 10.87B | -3.53B | |
Tangible asset value | 44.12B | 50.95B | 44.75B | 45.54B | 48.4B | |
Net current asset value | -89.49B | -101B | -123.75B | -138.76B | -84.96B | |
Invested capital | 0.2 | 0.05 | 0.04 | 0.06 | 0.03 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 4.69B | 5.02B | 6.38B | 7.6B | 5.79B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.14 | 0.15 | 0.16 | 0.05 | 0.09 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2020-12-31 | 2021-06-30 | 2021-12-31 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.11 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0.03 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0.03 | 0 | 0 | 0 | 0 | |
Cash per share | 0.03 | 0 | 0 | 0 | 0 | |
Book value per share | 0.1 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0.09 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0.1 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 150.38B | 0 | 0 | 0 | 0 | |
Enterprise value | 151.19B | 952.77M | 758.59M | 1.39B | 1.27B | |
P/E ratio | 29.35 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 2.78 | 0 | 0 | 0 | 0 | |
POCF ratio | 10.68 | 0 | 0 | 0 | 0 | |
PFCF ratio | 11.88 | 0 | 0 | 0 | 0 | |
P/B Ratio | 3.13 | 0 | 0 | 0 | 0 | |
PTB ratio | 3.13 | 0 | 0 | 0 | 0 | |
EV to sales | 2.79 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 71.45 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 10.74 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 11.94 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.01 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0.08 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.04 | 0.04 | 0.06 | 0.03 | 0.03 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | 0.39 | 0 | 0 | 0 | 0 | |
Current ratio | 2.12 | 1.96 | 2.41 | 0.1 | 0.58 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 10.99 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.04 | 0.04 | |
Capex to operating cash flow | -0.1 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.03 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.08 | 0 | 0 | 0 | 0 | |
ROIC | 0.02 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0.01 | 0 | 0 | 0 | 0 | |
Graham Net | -0.25 | 0 | 0 | 0 | 0 | |
Working capital | 8.38B | 7.04B | 10.87B | -3.53B | -2.38B | |
Tangible asset value | 44.75B | 45.19B | 45.54B | 48.4B | 50.5B | |
Net current asset value | -123.75B | -127.34B | -138.76B | -84.96B | -84.41B | |
Invested capital | 0.04 | 0.04 | 0.06 | 0.03 | 0.03 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.03 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
RGSS.ME Frequently Asked Questions
What is Rosgosstrakh Insurance Company (Public Joint Stock Company) stock symbol ?
Rosgosstrakh Insurance Company (Public Joint Stock Company) is a RU stock and trading under the symbol RGSS.ME
What is Rosgosstrakh Insurance Company (Public Joint Stock Company) stock quote today ?
Rosgosstrakh Insurance Company (Public Joint Stock Company) stock price is $0.1256 today.
Is Rosgosstrakh Insurance Company (Public Joint Stock Company) stock public?
Yes, Rosgosstrakh Insurance Company (Public Joint Stock Company) is a publicly traded company.